Mefloquine HCl 250 mg Oral Tablet
RxNorm 835913
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 835913 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: mefloquine HCl 250 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Mefloquine hydrochloride 250 mg Oral Tablet
(Atom ID: 12341069)
PTPrescribable
Designated preferred name (PT):
Mefloquine (as mefloquine hydrochloride) 250 mg oral tablet
(Atom ID: 11437547)
PSNPrescribable
Prescribable Name (PSN):
Mefloquine HCl 250 mg Oral Tablet
(Atom ID: 7739430)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely mefloquine (as mefloquine hydrochloride) 250 mg/1 each conventional release oral tablet (clinical drug)
(Atom ID: 11440270)
Patient Education
Mefloquine
Mefloquine is used to treat malaria (a serious infection that is spread by mosquitoes in certain parts of the world and can cause death) and to prevent malaria in travelers who visit areas where malaria is common. Mefloquine is in a class of medications called antimalarials. It works by killing the organisms that cause malaria.
[Learn More]
* Please review the disclaimer below.